Skip to content

Venture

LOGO 5-01

Affiliations

Rockefeller University

Technologies

Therapeutic

Indication

Infectious Disease

Platform technology to produce recombinant therapeutic antibodies against Staphylococcus aureus and other pathogens, targeting cell wall carbohydrates not adequately recognized by the human immune system.

 

Team:

Assaf Raz, PhD – CSO
Vincent A. Fischetti, PhD – Head of SAB